Ligand validation:6CRG

5OD: 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine

5OD is a Ligand Of Interest in 6CRG designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6CRG_5OD_A_601	37%	24%	0.231	0.932	1.5	1.6	4	7	0	0	100%	1
6CRG_5OD_B_601	22%	31%	0.29	0.905	1.53	1.24	4	4	0	0	100%	1
5EHR_5OD_B_601	81%	29%	0.102	0.954	1.2	1.63	3	8	1	0	100%	1
6BMY_5OD_A_601	79%	29%	0.108	0.954	1.21	1.61	2	8	0	0	100%	1
6BMU_5OD_A_601	76%	25%	0.11	0.946	1.36	1.66	2	8	0	0	100%	1
6CMR_5OD_A_601	75%	14%	0.104	0.936	2.24	1.67	8	5	0	0	100%	1
6BMW_5OD_B_601	66%	26%	0.125	0.93	1.16	1.81	2	11	0	0	100%	1
6CMS_5OD_A_601	61%	13%	0.152	0.942	2.22	1.76	8	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.